IDX — Integral Diagnostics Cashflow Statement
0.000.00%
Last trade - 00:00
- AU$576.56m
- AU$920.06m
- AU$440.79m
- 72
- 44
- 38
- 53
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Changes in Working Capital | -53.2 | -4.87 | -2.13 | -5.42 | -3.53 |
Other Operating Cash Flow | |||||
Cash from Operating Activities | 33.9 | 54.3 | 69.6 | 37.1 | 71.4 |
Capital Expenditures | -18.7 | -25.9 | -20.3 | -27.8 | -44 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -76.3 | -67.7 | -36.4 | -27.9 | -85 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -95 | -93.5 | -56.7 | -55.7 | -129 |
Financing Cash Flow Items | -0.052 | -3.51 | -0.139 | -2.88 | 0 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 61.5 | 75.4 | -7.83 | 81.1 | -31.8 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.123 | 37 | 4.24 | 61 | -89.3 |